Trial Details
COMPLETEDBasic Information
| Clinical ID | c4516 |
|---|---|
| Identifier | NCT00394186 |
| Trial Title | A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome (IBS) |
| Interventions | DRUG: GW427353|DRUG: Placebo |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | New South Wales |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2006-08 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |